Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Acinetobacter baumannii among horses entering a veterinary teaching hospital: The contemporary “Trojan Horse”.
Abstract: Pathogens frequently associated with multi-drug resistant (MDR) phenotypes, including extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) and Acinetobacter baumannii isolated from horses admitted to horse clinics, pose a risk for animal patients and personnel in horse clinics. To estimate current rates of colonization, a total of 341 equine patients were screened for carriage of zoonotic indicator pathogens at hospital admission. Horses showing clinical signs associated with colic (n = 233) or open wounds (n = 108) were selected for microbiological examination of nostril swabs, faecal samples and wound swabs taken from the open wound group. The results showed alarming carriage rates of Gram-negative MDR pathogens in equine patients: 10.7% (34 of 318) of validated faecal specimens were positive for ESBL-E (94%: ESBL-producing Escherichia coli), with recorded rates of 10.5% for the colic and 11% for the open wound group. 92.7% of the ESBL-producing E. coli were phenotypically resistant to three or more classes of antimicrobials. A. baumannii was rarely detected (0.9%), and all faecal samples investigated were negative for Salmonella, both directly and after two enrichment steps. Screening results for the equine nostril swabs showed detection rates for ESBL-E of 3.4% among colic patients and 0.9% in the open wound group, with an average rate of 2.6% (9/340) for both indications. For all 41 ESBL-producing E. coli isolated, a broad heterogeneity was revealed using pulsed-field gel electrophoresis (PFGE) patterns and whole genome sequencing (WGS) -analysis. However, a predominance of sequence type complex (STC)10 and STC1250 was observed, including several novel STs. The most common genes associated with ESBL-production were identified as blaCTX-M-1 (31/41; 75.6%) and blaSHV-12 (24.4%). The results of this study reveal a disturbingly large fraction of multi-drug resistant and ESBL-producing E. coli among equine patients, posing a clear threat to established hygiene management systems and work-place safety of veterinary staff in horse clinics.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study investigates the rate of carriage of multi-drug resistant pathogens, specifically extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Acinetobacter baumannii, in horses admitted to a veterinary hospital. The researchers found an alarming rate of these pathogens in the studied equine population, posing a significant challenge to hospital hygiene and staff safety.
Study Background
The research focused on two major pathogenic bacteria: ESBL-producing Escherichia coli and Acinetobacter baumannii. These pathogens have been associated with multi-drug resistant (MDR) phenotypes and pose a potential risk to animal patients and workers in horse clinics. The high resistance of these bacteria to multiple classes of antibiotics makes it challenging to treat infections triggered by them.
Methodology
A total of 341 equine patients admitted to the hospital were screened for the presence of these pathogens. The researchers specifically selected horses showing clinical signs associated with colic or those with open wounds.
The researchers employed microbiological examination of nostril swabs, fecal samples, and wound swabs taken from the group with open wounds.
Results
The study offered alarming findings: 10.7% (34 out of 318) of validated fecal samples were positive for ESBL-E, with most being ESBL-producing E. coli.
Among these E. coli, 92.7% were resistant to three or more classes of antimicrobials, highlighting the extent of multi-drug resistance.
Acinetobacter baumannii was detected at a significantly lower rate of 0.9%, and no Salmonella was detected in any of the fecal samples.
Nostril swabs showed detection rates for ESBL-E of 3.4% among colic patients and 0.9% in the open wound group.
All ESBL-producing E. coli isolated were analyzed using pulsed-field gel electrophoresis (PFGE) patterns and whole genome sequencing (WGS), revealing a broad heterogeneity of these bacteria.
The most common genes associated with ESBL-production were blaCTX-M-1 and blaSHV-12.
Conclusion
The findings painted an alarming picture of antibiotic resistance, revealing a large fraction of multi-drug resistant and ESBL-producing E. coli among equine patients.
This poses a clear threat to established hygiene management systems and workplace safety of veterinary staff in horse clinics, emphasizing the need for improved infection control protocols and possibly novel antibiotic strategies.
Cite This Article
APA
Walther B, Klein KS, Barton AK, Semmler T, Huber C, Wolf SA, Tedin K, Merle R, Mitrach F, Guenther S, Lübke-Becker A, Gehlen H.
(2018).
Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Acinetobacter baumannii among horses entering a veterinary teaching hospital: The contemporary “Trojan Horse”.
PLoS One, 13(1), e0191873.
https://doi.org/10.1371/journal.pone.0191873
Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Advanced Light and Electron Microscopy, Robert Koch Institute, Berlin, Germany.
Klein, Katja-Sophia
Equine Clinic, Surgery and Radiology, Freie Universität Berlin, Berlin, Germany.
Barton, Ann-Kristin
Equine Clinic, Surgery and Radiology, Freie Universität Berlin, Berlin, Germany.
Semmler, Torsten
Microbial Genomics (NG1), Robert Koch Institute, Berlin, Germany.
Huber, Charlotte
Advanced Light and Electron Microscopy, Robert Koch Institute, Berlin, Germany.
Wolf, Silver Anthony
Microbial Genomics (NG1), Robert Koch Institute, Berlin, Germany.
Tedin, Karsten
Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Merle, Roswitha
Institute for Veterinary Epidemiology and Biostatistics, Freie Universität Berlin, Berlin, Germany.
Mitrach, Franziska
Institute of Biotechnology, Faculty of Environment and Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany.
Guenther, Sebastian
Institute of Animal and Environmental Hygiene, Freie Universität Berlin, Berlin Germany.
Institute of Pharmacy, Pharmaceutical Biology, Ernst Moritz Arndt Universität Greifswald, Greifswald Germany.
Lübke-Becker, Antina
Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Gehlen, Heidrun
Equine Clinic, Surgery and Radiology, Freie Universität Berlin, Berlin, Germany.
MeSH Terms
Acinetobacter baumannii / genetics
Acinetobacter baumannii / metabolism
Animals
Electrophoresis, Gel, Pulsed-Field
Escherichia coli / genetics
Escherichia coli / metabolism
Genes, Bacterial
Horses / microbiology
Hospitals, Animal
Hospitals, Teaching
beta-Lactamases / biosynthesis
Conflict of Interest Statement
Competing Interests: The authors have declared that no competing interests exist.
Morley PS. Evidence-based infection control in clinical practice: If you buy clothes for the emperor, will he wear them?. Journal of Veterinary Internal Medicine 2013;27(3):430–8.
Wright JG JS, Holman RC, Marano NN, McQuiston JH. Infection control practices and zoonotic disease risks among veterinarians in the United States.. J Am Vet Med Assoc 2008;15(232(12)):1863–72.
Willemsen I, Oome S, Verhulst C, Pettersson A, Verduin K, Kluytmans J. Trends in Extended Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriaceae and ESBL Genes in a Dutch Teaching Hospital, Measured in 5 Yearly Point Prevalence Surveys (2010–2014).. PLoS One 2015;10(11):e0141765.
Guenther S, Semmler T, Stubbe A, Stubbe M, Wieler LH, Schaufler K. Chromosomally encoded ESBL genes in Escherichia coli of ST38 from Mongolian wild birds.. J Antimicrob Chemother 2017;72(5):1310–3.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Supplement M100-S22; Wayne, PA, USA.. 2012;32/ 2.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard.. Wayne, PA,2008.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21.. Wayne, PA, USA. 2011.
Klotz P, Gottig S, Leidner U, Semmler T, Scheufen S, Ewers C. Carbapenem-resistance and pathogenicity of bovine Acinetobacter indicus-like isolates.. PLoS One 2017;12(2):e0171986.
Bednorz C, Guenther S, Oelgeschlager K, Kinnemann B, Pieper R, Hartmann S. Feeding the probiotic Enterococcus faecium strain NCIMB 10415 to piglets specifically reduces the number of Escherichia coli pathotypes that adhere to the gut mucosa.. Appl Environ Microbiol 2013;79(24):7896–904.
Carattoli A, Zankari E, Garcia-Fernandez A, Voldby Larsen M, Lund O, Villa L. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.. Antimicrob Agents Chemother 2014;58(7):3895–903.
von Mentzer A, Connor TR, Wieler LH, Semmler T, Iguchi A, Thomson NR. Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution.. 2014;46:1321–6.
Wieler LH, Walther B, V S., G S., Lübke-Becker A. Infections with multidrug-resistant bacteria: Has the post-antibiotic era arrived in companion animals?. In: Sing A, editor. Zoonoses—Infections Affecting Humans and Animals: Focus on Public Health Aspects. I. Oberschleißheim: Springer; 2015. p. 433ff.
Dolejska M, Duskova E, Rybarikova J, Janoszowska D, Roubalova E, Dibdakova K. Plasmids carrying blaCTX-M-1 and qnr genes in Escherichia coli isolates from an equine clinic and a horseback riding centre.. J Antimicrob Chemother 2011;66(4):757–64.
Schaufler K, Bethe A, Lubke-Becker A, Ewers C, Kohn B, Wieler LH. Putative connection between zoonotic multiresistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in dog feces from a veterinary campus and clinical isolates from dogs.. Infect Ecol Epidemiol 2015;5:25334.
Tamang MD, Nam HM, Jang GC, Kim SR, Chae MH, Jung SC. Molecular characterization of extended-spectrum-beta-lactamase-producing and plasmid-mediated AmpC beta-lactamase-producing Escherichia coli isolated from stray dogs in South Korea.. Antimicrob Agents Chemother 2012;56(5):2705–12.
Loncaric I, Stalder GL, Mehinagic K, Rosengarten R, Hoelzl F, Knauer F. Comparison of ESBL—and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in Austria.. PLoS One 2013;8(12):e84048.
Qin X, Hu F, Wu S, Ye X, Zhu D, Zhang Y. Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains.. PLoS One 2013;8(4):e61169.
Ewers C, Klotz P, Leidner U, Stamm I, Prenger-Berninghoff E, Gottig S. OXA-23 and ISAba1-OXA-66 class D beta-lactamases in Acinetobacter baumannii isolates from companion animals.. Int J Antimicrob Agents 2017;49(1):37–44.
Huijbers PM, de Kraker M, Graat EA, van Hoek AH, van Santen MG, de Jong MC. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density.. Clin Microbiol Infect 2013;19(6):E256–9.
van Hoek AH, Schouls L, van Santen MG, Florijn A, de Greeff SC, van Duijkeren E. Molecular characteristics of extended-spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community.. PLoS One 2015;10(6):e0129085.
Benedict KM, Morley PS, Van Metre DC. Characteristics of biosecurity and infection control programs at veterinary teaching hospitals.. J Am Vet Med Assoc 2008;233(5):767–73. Epub 2008/09/04.
Zendri F, Schmidt V, Mauder N, Loeffler A, Jepson RE, Isgren C, Pinchbeck G, Haldenby S, Timofte D. Rapid typing of Klebsiella pneumoniae and Pseudomonas aeruginosa by Fourier-transform Infrared spectroscopy informs infection control in veterinary settings. Front Microbiol 2024;15:1334268.
Lupo A, Valot B, Saras E, Drapeau A, Robert M, Bour M, Haenni M, Plésiat P, Madec JY, Potron A. Multiple host colonization and differential expansion of multidrug-resistant ST25-Acinetobacter baumannii clades. Sci Rep 2023 Dec 9;13(1):21854.
Thomson P, García P, Río CD, Castro R, Núñez A, Miranda C. Antimicrobial Resistance and Extended-Spectrum Beta-Lactamase Genes in Enterobacterales, Pseudomonas and Acinetobacter Isolates from the Uterus of Healthy Mares. Pathogens 2023 Sep 8;12(9).
Werner G, Abu Sin M, Bahrs C, Brogden S, Feßler AT, Hagel S, Kaspar H, Köck R, Kreienbrock L, Krüger-Haker H, Maechler F, Noll I, Pletz MW, Tenhagen BA, Schwarz S, Walther B, Mielke M. [Therapy-relevant antibiotic resistances in a One Health context]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2023 Jun;66(6):628-643.
Wareth G, Neubauer H, Sprague LD. Acinetobacter baumannii - a neglected pathogen in veterinary and environmental health in Germany. Vet Res Commun 2019 Feb;43(1):1-6.